References
- J. Pascual, G. Attard, F.-C. Bidard et al., ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group, Annals of Oncology, volume 33, issue 8, p750–768, August 2022
- Katrisiou M., Zarkavelis G., Pentheroudakis G. et al., Clinical Application of Next-Generation Sequencing as A Liquid Biopsy Technique in Advanced Colorectal Cancer: A Trick or A Treat? Cancers (Basel). 2019 Oct 16;11(10):1573. doi: 10.3390/cancers11101573.
- CJ Clopper and ES Pearson, “The use of confidence or fiducial limits illustrated in the case of the binomial.” Biometrika 26:404–413, 1934.
- Watson PF, Petrie A. Method agreement analysis: a review of correct methodology. Theriogenology. 2010 Jun;73(9):1167–79. doi: 10.1016/j.theriogenology.2010.01.003. PMID: 20138353.
- Kastrisiou M, Zarkavelis G., Kougioumtzi A., et al., Development and Validation of a Targeted ‘Liquid’ NGS Panel for Treatment Customization in Patients with Metastatic Colorectal Cancer, Diagnostics (Basel). 2021 Dec; 11(12): 2375
- De Mattos-Arruda L., Siravegna G. How to use liquid biopsies to treat patients with cancer., DOI: https://doi.org/10.1016/j.esmoop.2021.100060
- Vlagea A, Falagan S, Gutiérrez-Gutiérrez G, et al. Antinuclear antibodies and cancer: A literature review. Crit Rev Oncol Hematol. 2018;127:42–49. doi:10.1016/j.critrevonc.2018.05.002
- Heegaard NH, West-Nørager M, Tanassi JT, et al. Circulating antinuclear antibodies in patients with pelvic masses are associated with malignancy and decreased survival. PLoS One. 2012;7(2):e30997. doi:10.1371/journal.pone.0030997
- Hosseini MM, Geramizadeh B, Shakeri S, Karimi MH. Intrascrotal solitary neurofibroma: A case report and review of the literature. Urol Ann. 2012;4(2):119–21.
- Bian X, Xia M, Xie H, Cui F, Chen J, Zhang R, et al.. Solitary testicular neurofibromatosis with testicular abscess: a case report. Transl Androl Urol. 2020;9(3):1437–41